CUSIP: G3141W114
What is CUSIP G3141W114?
CUSIP G3141W114 identifies EUCRU - EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP G3141W114:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q2 | 0 | $0 | -$6,722,364 | 0 | |
| 2023 Q1 | 649,018 | $6,722,364 | -$29,196 | $10.36 | 4 |
| 2022 Q4 | 651,953 | $6,506,088 | -$4,859,778 | $9.98 | 6 |
| 2022 Q3 | 1,136,824 | $11,392,000 | -$4,731,497 | $10.02 | 11 |
| 2022 Q2 | 1,609,868 | $16,059,000 | -$2,500,032 | $10.00 | 15 |
| 2022 Q1 | 1,862,478 | $18,381,000 | -$8,549,145 | $9.86 | 18 |
| 2021 Q4 | 2,713,768 | $27,083,000 | -$15,191,173 | $9.98 | 14 |
| 2021 Q3 | 4,145,275 | $41,232,000 | -$1,226,468 | $9.95 | 17 |
| 2021 Q2 | 4,266,479 | $43,488,000 | -$7,987,379 | $10.20 | 18 |
| 2021 Q1 | 5,060,629 | $50,907,000 | -$36,795,972 | $10.06 | 23 |
| 2020 Q4 | 8,490,544 | $90,392,000 | +$83,608,000 | $10.66 | 37 |